These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19957897)

  • 1. [Complications of portal hypertension in the liver cirrhosis].
    Ivashkin VT
    Ross Fiziol Zh Im I M Sechenova; 2009 Oct; 95(10):1074-92. PubMed ID: 19957897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary complications in cirrhosis.
    Sussman NL; Kochar R; Fallon MB
    Curr Opin Organ Transplant; 2011 Jun; 16(3):281-8. PubMed ID: 21543981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac involvement in liver cirrhosis.
    Gatta A; Merkel C; Sacerdoti D; Angeli P
    Ann Ital Med Int; 1993; 8(4):244-7. PubMed ID: 8161481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic changes and its significance after liver transplantation for cirrhosis and portal hypertension].
    Zhang TL
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1689-92. PubMed ID: 19094724
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
    Stanley AJ; Bouchier IA; Hayes PC
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of splenic artery embolization in treating complicated liver cirrhosis].
    Kalita NIa; Bulanov KI; Nikishin LF; Kondratiuk VA; Egorova ON
    Klin Khir; 1995; (9-10):5-9. PubMed ID: 8697221
    [No Abstract]   [Full Text] [Related]  

  • 7. Computational hemodynamics of portal vein hypertension in hepatic cirrhosis patients.
    Li X; Wang XK; Chen B; Pu YS; Li ZF; Nie P; Su K
    Biomed Mater Eng; 2015; 26 Suppl 1():S233-43. PubMed ID: 26406008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutics for portal hypertension and fibrosis in chronic liver disease.
    Guixé-Muntet S; Zhu CP; Xie WF; Gracia-Sancho J
    Pharmacol Ther; 2020 Nov; 215():107626. PubMed ID: 32659305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
    Bizer LS
    Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Embolization of the hepatic artery in the treatment of cirrhosis of the liver].
    Granov AM; Borisov AE; Ryzhkov VK; Borisova NA; Zemlianoĭ VP
    Vestn Khir Im I I Grek; 1984 Feb; 132(2):117-21. PubMed ID: 6719707
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physiopathology of portal hypertension in liver cirrhosis].
    Cervela LA
    Rev Esp Enferm Apar Dig; 1973 Jan; 39(2):223-38. PubMed ID: 4690385
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiologic basis for the medical management of portal hypertension.
    Poordad FF; Sigal SH; Brown RS
    Expert Opin Pharmacother; 2009 Feb; 10(3):453-67. PubMed ID: 19191681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver cirrhosis as a multisystem disease].
    Bettinger D; Thimme R; Schultheiß M
    Dtsch Med Wochenschr; 2024 Jun; 149(12):690-695. PubMed ID: 38781992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Doppler blood flow measurements in the portal system].
    Kalina Z; Scieszka J; Maślankiewicz A
    Pol Przegl Radiol; 1988; 52(6):284-6. PubMed ID: 3077452
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver cirrhosis.
    Tsochatzis EA; Bosch J; Burroughs AK
    Lancet; 2014 May; 383(9930):1749-61. PubMed ID: 24480518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphofunctional state of the spleen and clinical results of embolization of the splenic artery in liver cirrhosis patients with portal hypertension].
    Vakhidov AV; Nazyrov FG; Deviatov AV; Murtaev NM; Vorozheĭkin VM
    Khirurgiia (Mosk); 1988 Jan; (1):74-8. PubMed ID: 3352174
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C
    J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
    García-Pagán JC; Gracia-Sancho J; Bosch J
    J Hepatol; 2012 Aug; 57(2):458-61. PubMed ID: 22504334
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal hypertension complications].
    Xu K; Han GH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):481-2. PubMed ID: 22152232
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of isosorbide dinitrate (Isoket Pharma-Schwartz) in patients with liver cirrhosis].
    Cervinka J; Kaláb M; Perlík F; Kordac V; Marecek Z; Chmel J; Kodadová J; Horejsí A
    Cas Lek Cesk; 1986 Jul; 125(30):940-3. PubMed ID: 3731233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.